Ariad Pharmaceuticals Inc. (ARIA) rose 3% on Friday, and shares are up by another 3.5% on Monday morning to $7.48 after Jefferies raised its rating up to Buy from Hold.
Atlantic Power Corp. (AT) had a 9% gain on Friday and shares are marginally higher on Monday morning after confirming, or reconfirming, that it is under a strategic options review with Goldman Sachs.
B/E Aerospace Inc. (BEAV) put itself up for sale over the weekend, for a “strategic options” review with Citigroup. Shares are up almost 9% and above $96 — and Sterne Agee gave a sum-of-the-parts analysis for $121 per share. We pointed out over the weekend that the consensus price target was closer to $100.
CytRx Corp. (CYTR) is on the move higher after reporting that it showed a significant increase in the median progression-free survival over data completed in Phase 1b/2 progression-free survival and overall survival Aldoxorubicin data in second-line soft tissue sarcoma. This is for ASCO and ESMO presentations. Shares were down 9% on Friday and are gaining much of that back on Monday morning.
Harsco Corp. (HSC) is seeing a higher trading indication, although somewhat muted, on news in the Barron’s weekend print edition that the industrial is underappreciated and undervalued by 20% or so.
Sina Corp. (SINA) is down on two pieces of data. Oppenheimer downgraded it to Perform, and the company was fined by China for indecent content. Sina shares are down 3.5% at $46.43, very close to a 52-week low of $46.25 and down about 50% from its 52-week high.
Filed under: Investing Tagged: ARIA, BEAV, CYTR, SINA
- Investment & Company Information